There is an element of physics when it comes to matching a frame to the patient’s head, with the forces of weight and friction playing a big part in overall comfort and fit, writes LEIGH ROBINSON. Read more
Latanoprost – a lasting glaucoma breakthrough
Latanoprost was a game-changing glaucoma therapy and still remains a go-to treatment for many ophthalmologists more than two decades later. PROFESSOR JOHN GRIGG – an investigator on an important clinical trial for the drug in 1996 – traces its history and explains how it fits into the treatment algorithm today.
Standing up for dry eye patients
As a veteran dry eye patient, I have experienced many highs and lows. From feeling temporary relief via expert treatment through to complex psychological trauma from debilitating symptoms.
Raising your profile and profits with ophthalmic lens technology
Differentiation and educating patients on varying lens qualities is one of independent optometry’s greatest challenges today. But an increasing number of practices are finding success with a high-precision eye measurement device that’s also raising sales by up to a third.
Elective surgery post-COVID
An elective surgery shutdown as part of the COVID-19 response wreaked havoc on an already-stretched hospital system last year. Insight checks in on how each state is faring one year on. Read more
Vertex distance, every millimetre counts
High-powered lenses still require the back vertex distance to be measured otherwise the wearer may not get the best out of their lenses. Steven Daras dissects this underused dispensing measurement. Read more
Caring for stroke or brain injury patients
Orthoptists are uniquely positioned to assess and manage the visual needs of acquired brain injury and rehabilitation patients, writes orthoptist and academic MICHELLE COURTNEY-HARRIS. Read more
Streamlining the optometric Medicare schedule
With optometrists performing three-quarters of all eye exams in Australia, the optometric Medicare schedule has a major bearing on the quality of eye health in this country. Insight dives into the MBS Taskforce’s endorsed report that could reshape primary eyecare for decades to come.
Overhauling the ophthalmology Medicare schedule – is it worth it?
The MBS Taskforce has published its final report into ophthalmology items containing recommendations that have come under intense scrutiny from the sector. But it wasn’t all bad news. Insight examines what the future ophthalmology care model may look like under Medicare.
The world of neuro-ophthalmology
Neuro-ophthalmology (N/O) is an interesting subspecialty because it crosses boundaries. Almost exclusively a ‘medical–type’ specialty rather than ‘surgical’, about half of its practitioners in Australia and New Zealand are neurologists and the other half are ophthalmologists.